Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Molecular Genetics and New Medication Strategies for Opioid Addiction.

Hurd YL, O'Brien CP.

Am J Psychiatry. 2018 Oct 1;175(10):935-942. doi: 10.1176/appi.ajp.2018.18030352. Epub 2018 Aug 2.

PMID:
30068261
2.

Cannabidiol: Swinging the Marijuana Pendulum From 'Weed' to Medication to Treat the Opioid Epidemic.

Hurd YL.

Trends Neurosci. 2017 Mar;40(3):124-127. doi: 10.1016/j.tins.2016.12.006. Epub 2017 Feb 2.

PMID:
28162799
3.

A urinary test procedure for identification of cannabidiol in patients undergoing medical therapy with marijuana.

Wertlake PT, Henson MD.

J Pain Res. 2016 Feb 12;9:81-5. doi: 10.2147/JPR.S96856. eCollection 2016.

4.

Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances.

Ren Y, Whittard J, Higuera-Matas A, Morris CV, Hurd YL.

J Neurosci. 2009 Nov 25;29(47):14764-9. doi: 10.1523/JNEUROSCI.4291-09.2009.

5.

Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice.

Bhargava HN.

Psychopharmacology (Berl). 1976 Sep 29;49(3):267-70.

PMID:
826944
6.

Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats.

Hine B, Torrelio M, Gershon S.

Res Commun Chem Pathol Pharmacol. 1975 Sep;12(1):185-8.

PMID:
1237925
7.

Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol.

Hine B, Friedman E, Torrelio M, Gershon S.

Science. 1975 Feb 7;187(4175):443-5.

PMID:
1167428

Supplemental Content

Loading ...
Support Center